India’s Sensex Ends Two-Day Drop as Exporters Rise on Weak RupeeRajhkumar K Shaaw
Indian stocks climbed, with the benchmark gauge halting two days of declines, as drugmakers and software exporters gained on optimism that a weak rupee will boost the value of their repatriated profits.
Sun Pharmaceutical Industries Ltd., Cipla Ltd. and Lupin Ltd., the top health-care companies by market value, were among the biggest gainers on the S&P BSE Sensex. Infosys Ltd. climbed to a record and Wipro Ltd. rose to a one-month high. Reliance Industries Ltd., which gets 65 percent of its revenue selling fuels abroad, gained 1.1 percent.
The Sensex added 0.4 percent to 27,931.64 at the close, after changing direction at least six times. Speculation that India is less vulnerable to a slowdown in China and the rising cost of dollar financing has made the Sensex the biggest gainer among the four largest emerging markets in the past two months. Foreigners have bought $6.9 billion of local shares in 2015, the highest after Japan, data compiled by Bloomberg show.
“The kind of reaction we’re seeing in China can add a lot of volatility to Indian markets but that’s a near-term thing,” Nitasha Shankar, vice president for equity research at Yes Securities Ltd. in Mumbai, said in an interview with Bloomberg TV India. “The way our fundamental strength is playing out we should see a lot of funds returning to India.”
She is recommending drugmakers and software exporters amid a weak rupee and improving demand outlook in Europe. The rupee has fallen 1.8 percent this month as India’s trade gap widened and the yuan devaluation spurred a selloff in Asian currencies.
The 52 percent plunge in Brent oil prices in the past year has helped cool India’s inflation, improved government finances and allowed the central bank to cut interest rates three times in 2015. Wholesale prices declined by the most on record, data showed on Friday, and consumer-price gains were lower than estimated, data released Wednesday showed.
Global funds have still withdrawn a net $72 million from Indian equities in August, part of the $2.7 billion they’ve pulled from eight Asian market tracked by Bloomberg.
RBI Governor Raghuram Rajan maintained the repo rate at 7.25 percent on Aug. 4, and said he will assess developments, including the expected increase in U.S.rates, before cutting further. Minutes of the Federal Reserve’s July meeting are due today, which may offer clues on the timing of its first rate increase since 2006.
“Investors are betting the rupee will depreciate further if the RBI cuts rates and the Fed raises rates,” Chokkalingam G., managing director at Equinomics Research Pvt. in Mumbai, said by phone. “Exporters will benefit in such a scenario.”
Sun Pharma rallied to a one-month high, while Cipla rose 1.8 percent and Lupin gained the most this month. Infosys climbed 1 percent to a record and Wipro gained 2.4 percent to the highest close since July 23.
Amtek Auto Ltd., a car-parts maker, plunged 31 percent to 89.2 rupees. The BSE Ltd. said today it will exclude the company’s futures, options contracts from Oct. 30. The stock has crashed 41 percent since reporting quarterly loss versus profit a year earlier after market hours on Friday.
The Sensex has risen 1.6 percent this year and trades at 15.8 times projected 12-month earnings, data compiled by Bloomberg show. The MSCI Emerging Markets Index is valued at a multiple of 10.9.